Next-generation allergy vaccines to be developed in Finland to create effective and safe desensitization therapies
Friday, October 21, 2011 - 10:00
in Health & Medicine
VTT Ventures Oy has established a spin-off which develops next-generation allergy vaccines. The spin-off is called Desentum Oy, and its operations are based on a VTT patented technology. Years of research, testing and official approval cycles are still required before the vaccines are ready for launch.